Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 9th:
Vericel Corporation (VCEL - Free Report) : This cloud-based platform solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.
Vericel's shares gained 23.4% over the last one month in contrast to the S&P 500’s decrease of 2.6%. The company possesses a Momentum Score of A.
Pacira Pharmaceuticals, Inc. (PCRX - Free Report) : This specialty pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping 46.3% over the last 60 days.
Pacira Pharmaceuticals’ shares gained 7.5% over the last one month. The company possesses a Momentum Score of A.
NeoGenomics, Inc. (NEO - Free Report) : This operator of a network of cancer-focused genetic testing laboratories has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20% over the last 60 days.
NeoGenomics’ shares gained 25% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 9th:
Vericel Corporation (VCEL - Free Report) : This cloud-based platform solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.
Vericel's shares gained 23.4% over the last one month in contrast to the S&P 500’s decrease of 2.6%. The company possesses a Momentum Score of A.
Pacira Pharmaceuticals, Inc. (PCRX - Free Report) : This specialty pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping 46.3% over the last 60 days.
Pacira Pharmaceuticals’ shares gained 7.5% over the last one month. The company possesses a Momentum Score of A.
NeoGenomics, Inc. (NEO - Free Report) : This operator of a network of cancer-focused genetic testing laboratories has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20% over the last 60 days.
NeoGenomics’ shares gained 25% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on NEO - FREE
Get the latest research report on PCRX - FREE
Get the latest research report on VCEL - FREE